| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |